| Ocala Endodontics | |
|
3201 Sw 34th Ave Ste 204 Ocala FL 34474-8471 | |
| (352) 237-1202 | |
| (352) 237-7722 |
| Full Name | Ocala Endodontics |
|---|---|
| Speciality | Dentist - Endodontics |
| Location | 3201 Sw 34th Ave Ste 204, Ocala, Florida |
| Authorized Official Name and Position | Elizabeth C Nixon (OWNER) |
| Authorized Official Contact | 3522731202 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Ocala Endodontics 3201 Sw 34th Ave Ste 204 Ocala FL 34474-8471 Ph: (352) 237-1202 | Ocala Endodontics 3201 Sw 34th Ave Ste 204 Ocala FL 34474-8471 Ph: (352) 237-1202 |
| NPI Number | 1215199138 |
|---|---|
| Provider Enumeration Date | 07/01/2008 |
| Last Update Date | 07/01/2008 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215199138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223E0200X | Dentist - Endodontics | DN 14769 (Florida) | Primary |
News Archive
The Senate passed a $140 billion "jobs bill" Wednesday that will extend unemployment coverage, increase federal Medicaid funding, block cuts to physician pay and preserve numerous tax breaks and credits that would have expired without congressional action, The Christian Science Monitor reports. "Jobs trump the national debt. That's the message from a robust, bipartisan Senate vote…" (Chaddock, 3/10).
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign, have been filed.
A life-extending pill for advanced melanoma that The Institute of Cancer Research (ICR) and The Royal Marsden Hospital helped develop is now available in the UK.
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH) were presented today at the American Heart Association's Scientific Sessions.
Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).
› Verified 7 days ago
Healthy Smiles P.a Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 206 Sw 10th St, Ocala, FL 34471 Phone: 352-732-5437 Fax: 352-732-0390 | |
Ronald E Caylor, Dmd, Pa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1120 Se 18th Pl, Ocala, FL 34471 Phone: 352-732-4427 Fax: 352-732-4499 | |
Grand Oaks Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2575 Sw 42nd St, Suite 104-105, Ocala, FL 34471 Phone: 352-877-4926 Fax: 352-224-6154 | |
Christie Dental Of Ocala Central Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2710 Se 17th St, Ocala, FL 34471 Phone: 352-732-7050 | |
Oakridge Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 9590 Sw 200 Hwy, Suite 7, Ocala, FL 34481 Phone: 352-237-2262 Fax: 352-237-2270 | |
Heart Of Florida Health Center-the Centers Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1025 Sw 1st Ave, Ocala, FL 34471 Phone: 352-732-6599 Fax: 352-732-4816 | |
Dental Discovery, Pa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5481 Sw 60th St Unit 202, Ocala, FL 34474 Phone: 352-653-3161 |